Edition:
United Kingdom

People: Collegium Pharmaceutical Inc (COLL.OQ)

COLL.OQ on NASDAQ Stock Exchange Global Select Market

10.84USD
17 Jul 2019
Change (% chg)

-- (--)
Prev Close
$10.84
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
117,030
52-wk High
$21.19
52-wk Low
$10.42

Ciaffoni, Joseph 

Mr. Joseph J. Ciaffoni is the President, Chief Executive Officer, Director of Collegium Pharmaceutical Inc. Mr. Ciaffoni has served as our President and Chief Executive Officer since July 2018, and prior to that, served as our Executive Vice President and Chief Operating Officer since May 2017. Prior to joining us, Mr. Ciaffoni served as President, U.S. Branded Pharmaceuticals of Endo International plc, a specialty pharmaceutical company, from August 2016 to December 2016. Before that, from April 2012 to August 2016, Mr. Ciaffoni held various positions of increasing responsibility at Biogen Idec, including Senior Vice President, Global Specialty Medicines Group, Senior Vice President, U.S. Commercial and Vice President, U.S. Neurology Field Operations and Marketing. Prior to joining Biogen Idec, Mr. Ciaffoni was Executive Vice President and Chief Operating Officer of Shionogi Inc. and President of Shionogi Pharmaceuticals from July 2008 to October 2010. Mr. Ciaffoni also previously served as Vice President, Sales for Schering-Plough (now Merck) from May 2004 to June 2008, where he was responsible for the cholesterol franchise, and has held several commercial leadership roles at Sanofi-Synthelabo (now Sanofi) from January 2002 to April 2004 and Novartis from January 1994 to December 2001. Mr. Ciaffoni received a B.A. in Communications in 1993 and an M.B.A. in 2000, both from Rutgers, The State University of New Jersey.

Basic Compensation

Total Annual Compensation, USD 585,577
Restricted Stock Award, USD 1,208,340
Long-Term Incentive Plans, USD --
All Other, USD 1,711,390
Fiscal Year Total, USD 3,505,300

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 64,821 932,807.00
Name Fiscal Year Total

Michael Heffernan

4,694,040

Joseph Ciaffoni

3,505,300

Paul Brannelly

1,975,500

Alison Fleming

1,909,170

Shirley Kuhlmann

1,607,030

Scott Dreyer

1,976,910
As Of  31 Dec 2018